Home › Funds › Tri Locum Partners LP › TEVA

Tri Locum Partners LP position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

Tri Locum Partners LP reported holding 746,835 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q2 2026 13F filing — a position valued at US$25.3M, representing 3.11% of its reported portfolio and ranking #13 among its reported holdings. Tri Locum Partners LP has disclosed TEVA holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)746.84K sh
Reported value held$25.30M
Portfolio Weight3.11%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Tri Locum Partners LP's TEVA position evolved

Tri Locum Partners LP first disclosed a stake in TEVA in Q3 2023 at 2,632,893 shares (US$26.9M). The position peaked in Q4 2024 at 2,423,116 shares, worth US$53.4M. Across 11 filings, Tri Locum Partners LP increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 746,835 shares valued at US$25.3M — a reduction of -274,173 shares quarter over quarter.. Notable position changes include a 32% trim in Q4 2023 (shares rose 35% over the following quarter), a 56% trim in Q1 2025 (shares rose 9% over the following quarter), a 93% increase in Q2 2025 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.63M $26.86M New
Q4 2023 1.79M $18.73M Reduce
Q1 2024 2.22M $31.27M Add
Q2 2024 2.55M $41.44M Add
Q3 2024 2.76M $49.66M Add
Q4 2024 2.42M $53.41M Reduce
Q1 2025 1.06M $16.31M Reduce
Q2 2025 2.05M $34.31M Add
Q4 2025 1.44M $44.81M New
Q1 2026 1.02M $30.75M Reduce
Q2 2026 746.84K $25.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 43 other funds we track also report a position in TEVA — the largest reported positions include Harel Insurance Investments & Financial Services Ltd. (US$1.63B), Phoenix Financial Ltd. (US$1.45B), WCM INVESTMENT MANAGEMENT, LLC (US$1.38B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has Tri Locum Partners LP held TEVA?

Tri Locum Partners LP has disclosed TEVA holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

What is Tri Locum Partners LP's current position in TEVA?

As of Q2 2026, Tri Locum Partners LP holds 746.84K shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $25.30M, representing 3.11% of its reported portfolio and ranking #13.

Has Tri Locum Partners LP been buying or selling TEVA?

In the latest 13F filing (Q2 2026), Tri Locum Partners LP reduced its position in TEVA. The position peaked in Q4 2024 at 2.42M shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include Harel Insurance Investments & Financial Services Ltd., Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.